chr21-34792388-T-C
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4BA1
This summary comes from the ClinGen Evidence Repository: This c.1190A>G (p.Gln397Arg) missense variant has a MAF of 0.003624 (0.3624%, 53/14624, 202938 alleles) in the East Asian subpopulation of the gnomAD v2 cohort, which is ≥ 0.0015 (0.15%) (BA1). The high allele frequency accounts for reports of this variant in affected individuals: 2 heterozygous patients with AML (PMID:19808697), a homozygous patient with personal and family history of thrombocytopenia (PMID:30103613), and other reports of this variant in patients with MDS, AML, and T-ALL that have not been confirmed to be of germline origin (PMID:17910630, 24523240, 24792891, 24850867, 28157215, 29279377). Furthermore, an abstract indicated that a dual luciferase assay used to assess this variant's transactivation ability in K562 cells was normal, although this data was not published in a peer-reviewed format (Huang et al., 2009, ASH Abstract 3468 - https://ashpublications.org/blood/article/114/22/3468/132805/High-Frequency-of-C-Terminal-Frame-Shift-Mutations). This missense variant have a REVEL score <0.5 (0.238), and is not predicted by SpliceAI, MES, or SSF-like to have a splicing impact (BP4). In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the ClinGen Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BA1 and BP4. LINK:https://erepo.genome.network/evrepo/ui/classification/CA10014193/MONDO:0011071/008
Frequency
Consequence
NM_001754.5 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary thrombocytopenia and hematologic cancer predisposition syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, Ambry Genetics, G2P
- acute myeloid leukemiaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001754.5. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RUNX1 | MANE Select | c.1190A>G | p.Gln397Arg | missense | Exon 9 of 9 | ENSP00000501943.1 | Q01196-8 | ||
| RUNX1 | TSL:1 | c.1190A>G | p.Gln397Arg | missense | Exon 8 of 8 | ENSP00000300305.3 | Q01196-8 | ||
| RUNX1 | TSL:1 | c.1109A>G | p.Gln370Arg | missense | Exon 6 of 6 | ENSP00000340690.4 | Q01196-1 |
Frequencies
GnomAD3 genomes AF: 0.0000793 AC: 12AN: 151324Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000268 AC: 46AN: 171874 AF XY: 0.000207 show subpopulations
GnomAD4 exome AF: 0.0000481 AC: 68AN: 1414298Hom.: 0 Cov.: 35 AF XY: 0.0000429 AC XY: 30AN XY: 699014 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000792 AC: 12AN: 151448Hom.: 0 Cov.: 32 AF XY: 0.0000810 AC XY: 6AN XY: 74042 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at